复方磺胺嘧啶口灌给药在拟穴青蟹(Scylla paramamosain)体内药动学和组织分布与消除

研究了水温为(27±1)℃、盐度为10条件下,单剂量(100 mg/kg)口灌给药复方磺胺嘧啶(磺胺嘧啶SD∶甲氧苄啶TMP=5∶1)后,SD和TMP在拟穴青蟹(Scylla paramamosain)体内的药动学以及在肌肉、肝胰腺和鳃组织中的分布和消除规律。结果显示,拟穴青蟹口灌复方磺胺嘧啶后,血淋巴中SD和TMP药物浓度-时间关系曲线均符合一级吸收二室模型,SD和TMP的峰浓度(C_(max))分别为49.56 mg/L和2.79 mg/L,药时曲线下面积(AUC)分别为1417.6 mg/L·h和82.7 mg/L·h;肝胰腺是SD和TMP峰浓度最高的组织,其C_(max)分别为59.36 mg/kg和74.82 mg/kg。由此可见,大量TMP蓄积在肝胰腺中,进入血液循环的TMP很少。在鳃组织中,SD和TMP的C_(max)分别为51.89 mg/kg和42.58 mg/kg,消除半衰期分别为23.28 h和25.29 h;鳃组织中药物浓度比较高,且消除速度较快,推测其在药物代谢中承担着消除功能。在肌肉中,SD和TMP的C_(max)分别为44.95 mg/kg和10.09 mg/kg,消除半衰期分别为25.09 h和35.08 h。以0.1 mg/kg和0.05 mg/kg分别为SD和TMP的最高残留限量(MRL),95%置信区间,推算SD和TMP在拟穴青蟹肌肉中的理论休药期分别为290.6 h和302.8 h,在肝胰腺中分别为340.4 h和377.0 h。     

冬季不同海区拟穴青蟹可溶蛋白和糖含量比较

采用生物化学方法测定了福建厦门海区和浙江宁海海区冬季拟穴青蟹鳃、肝胰腺和肌肉中可溶性蛋白和可溶性糖的含量.结果显示,厦门海区拟穴青蟹冬季可溶性蛋白含量在鳃(4.02 mg/ml)、肝胰腺(3.12 mg/ml)和肌肉(4.35 mg/ml)中显著高于宁海海区拟穴青蟹鳃(2.49 mg/ml)、肝胰腺(2.22 mg/m...     

单次和连续药饵投喂方式下复方磺胺嘧啶在吉富罗非鱼体内的代谢消除规律

在120 mg/kg单次药饵投喂和首剂量投喂复方磺胺嘧啶(磺胺嘧啶∶甲氧苄啶=5∶1)120 mg/kg后,再按60 mg/kg的剂量连续5 d投喂条件下,采用HPLC法研究了复方磺胺嘧啶在吉富罗非鱼(Oreochromis niloticus)体内的代谢消除规律。结果显示,单次给药下磺胺嘧啶和甲氧苄啶在罗非鱼血浆、肌肉、肾脏和肝脏中的消除半衰期(t1/2ke)分别为16.82和5.99,23.40和13.49,13.43和6.53,15.9和11.02 h,甲氧苄啶在各组织中的消除均快于磺胺嘧啶。给药24 h内,药物在各组织中的比值(SD∶TMP)均在1~40∶1(除了肾脏4 h采样点为0.71)的理想抑菌浓度范围内,提示5∶1给药比例在罗非鱼上使用能够达到理想的体内抑菌效果。血浆较组织中具有更高的比值,这与甲氧苄啶在体内的快速分布特性一致。连续给药情况下,磺胺嘧啶的浓度较单次给药情况下显著提高,甲氧苄啶的浓度较单次给药并未显著提高,这可能与甲氧苄啶较快的代谢速率及体内快速分布有关。参考中华人民共和国农业部NY5070—2002号公告中对水产品中磺胺类药物总量最大残留限量(MRL)为0.1 mg/kg,甲氧苄啶MRL为0.05 mg/kg的规定,单次给药和连续给药情况下,计算的休药期结果一致,建议本实验条件下的休药期不低于12 d。     

恩诺沙星及其代谢产物环丙沙星在拟穴青蟹体内的药代动力学

采用高效液相色谱法,研究盐度33条件下恩诺沙星口灌和肌肉注射给药(剂量10 mg/kg)后,恩诺沙星及其代谢物环丙沙星在拟穴青蟹体内的药代动力学和组织分布。血淋巴和组织中药代动力学参数采用基于统计矩原理的非房室模型进行计算。恩诺沙星口灌和肌肉注射拟穴青蟹给药后,血药达峰快,分别为0.5 h和1 min,达峰浓度分别为12.90和31.86 μg/mL,曲线下面积(AUC)分别为216.1和816.8 μg/(mL·h)。恩诺沙星在拟穴青蟹组织中分布较广,口灌给药下肌肉和肝胰腺AUC分别为445.9和817.6 μg/(g·h),肌肉注射给药下的AUC分别为554.7和2 573.7 μg/(g·h)。与其它水产动物相比,恩诺沙星在拟穴青蟹体内消除速度为中等水平,口灌和肌肉注射恩诺沙星后血药消除半衰期(t_1/2z)分别为26.45和57.02 h,总体清除率(CL_z)分别为0.054和0.012 L/(h·kg)。恩诺沙星在拟穴青蟹体内代谢生成环丙沙星的量较少,口灌给药下血淋巴、肌肉和肝胰腺的AUC_CIP/AUC_ENR分别为6.66%、3.66%和4.78%,肌肉注射给药下,其相应值分别为4.16%、7.24%和1.48%,在拟穴青蟹体内起药效作用仍是以恩诺沙星为主。以C_max/MIC、AUC_0-24/MIC评价恩诺沙星在青蟹体内的药效作用,建议给拟穴青蟹以10 mg/kg剂量每隔24小时投喂一次恩诺沙星,对弧菌引起的细菌性疾病具有较好的防治效果。     

土霉素在锯缘青蟹体内的药物代谢和消除规律

采用高效液相色谱法检测土霉素,研究土霉素口灌给药途径下在锯缘青蟹体内的药代动力学。锯缘青蟹口灌给药土霉素50 mg/kg后,其血浆、肌肉和肝胰脏中的药峰浓度分别为16.78±1.98 mg/L、9.39±2.12μg/g和32.12±6.12μg/g,达峰时间分别为4 h、8 h和4 h。血浆中土霉素浓度-时间关系曲线符合一级吸收的二室开放动力学模型。土霉素在锯缘青蟹体内分布广泛,其表观分布容积(Vd)为2.129 L/kg;分布半衰期(t1/2α)和消除半衰期(t1/2β)分别为3.200 h和47.856 h,总体清除率(CLs)为0.063 mL/(kg.h)。肌肉和肝胰脏中土霉素浓度与时间关系的药动学参数采用统计矩原理分析,其消除半衰期(t1/2 z)分别为60.145 h和71.009 h,总体清除率(CLz)分别为0.054 g/(kg.h)和0.037 g/(kg.h)。土霉素在精巢和卵巢中达峰时间分别为8 h和12 h,峰浓度分别为9.83μg/g和10.26μg/g。给药后24 d时,血浆、肌肉、肝胰脏、精巢和卵巢中土霉素含量都已低于0.10μg/g。土霉素在锯缘青蟹体内消除比较缓慢。     

噁喹酸在凡纳滨对虾体内药动学和对弧菌的体外药效

采用高效液相色谱法,研究了复方噁喹酸粉药饵投喂在凡纳滨对虾体内药动学和组织中消除规律,同时检测了噁喹酸对对虾源弧菌的最小抑菌浓度(MIC),建立了药动/药效(PK/PD)关系,提出了用药方案和休药期建议。结果显示,复方噁喹酸粉拌饵投喂给药,噁喹酸给药剂量为30 mg/kg(体质量),凡纳滨对虾血浆噁喹酸浓度—时间关系曲线均符合一级吸收二室开放动力学模型。血淋巴中噁喹酸达峰浓度(Cmax)、达峰时间(Tmax)、曲线下面积(AUC0-24)和消除半衰期(t1/2z)分别为14.70 mg/L、2 h、244.6 mg/(L·h)和18.56 h;肌肉、肝胰腺和鳃的峰浓度(Cmax)分别为4.11、17.20和7.01 mg/kg,消除半衰期(t1/2z)分别为10.71、12.31和16.75 h。噁喹酸对132株弧菌的MIC主要分布在0.15~1.25μg/m L,MIC50和MIC90分别为0.62和1.25μg/m L。PK/PD相互关系参数Cmax/MIC90和AUC0-24/MIC90分别为11.76和195.7。研究表明,噁喹酸以30 mg/(kg体质量)剂量药饵给药,凡纳滨对虾能很好地吸收噁喹酸,可以有效地防治弧菌引起的细菌性疾病。     

磺胺甲噁唑在罗非鱼体内的药代动力学及组织浓度研究

研究了(19±1)℃水温条件下,以100 mg/kg剂量单次口腔灌药后,磺胺甲噁唑(SMZ)在罗非鱼的肌肉、血液、肝脏组织中的残留和消除规律.各组织中药物浓度由高效液相色谱法测得.研究结果表明,罗非鱼血液中的药物浓度符合一级吸收一室开放模式;消除相半衰期T1/2k8.70 h,吸收相半衰期T1/2kα0.94 h,达峰时间Tp3.38 h,达峰浓度Cmax18.41 μg/mL.建议SMZ在罗非鱼上的休药期为10 d.     

甲氧苄氨嘧啶在牙鲆体内的药代动力学研究

健康牙鲆口服剂量为100 mg/kg的甲氧苄氨嘧啶后,利用高效液相色谱测定药物在牙鲆肌肉、血液、肾脏、肝脏质量浓度变化,并通过3P87药动学软件分析数据。试验结果表明,甲氧苄氨嘧啶在肌肉、血液、肾脏、肝脏4种组织中均符合一级吸收二室开放模型,其在上述4种组织中的达峰时间(tmax)分别为18.72、12.942、3.13 h和19.49 h;达峰质量浓度分别为13.80、18.23、32.79、27.40μg/ml;消除半衰期分别为23.64、21.471、6.72 h和15.99 h。口服甲氧苄氨嘧啶,在牙鲆体内吸收与消除较慢,血药浓度高,维持时间长。     

口灌给药恩诺沙星在斑节对虾体内的药动学和组织中的消除规律研究

为指导恩诺沙星在斑节对虾(Penaeus monodon)细菌性疾病防治中的科学合理应用，采用高效液相色谱法，研究了在海水(盐度33)水温为(28.0±1.0)℃下，斑节对虾口灌恩诺沙星(剂量30 mg·kg^-1)后，体内恩诺沙星及其代谢产物环丙沙星的药动学和组织分布。给药后斑节对虾血淋巴恩诺沙星药物浓度-时间曲线关系符合一级吸收二室开放模型。恩诺沙星在血淋巴、肌肉和肝胰腺中的达峰时间T_max分别为1 h、2 h和2 h,药物峰浓度(C_max)分别为17.82 mg·L^-1、5.02 mg·kg^-1和96.75 mg·kg^-1。血淋巴、肌肉和肝胰腺中恩诺沙星消除半衰期t_1/2z分别为17.12 h、72.31 h和37.78 h,总体清除率(CL_z)分别为0.11 L·(h·kg)^-1、0.21 kg·(h·kg)^-1和0.02 kg·(h·kg)^-1     

3种磺胺类药物在中国对虾(Fenneropenaeus chinensis)体内的药代动力学特征

采用高效液相色谱法研究了3种磺胺类药物在中国对虾体内的药物代谢动力学特征,这3种磺胺类药物包括磺胺二甲嘧啶(SM2)、磺胺嘧啶(SD)及磺胺对甲氧嘧啶(SMD)。实验期间,中国对虾的养殖水温为(24.6±2.4)℃,单次口服3种磺胺类药物的剂量均为100 mg/kg。结果显示,3种磺胺类药物在中国对虾体内的血药经时过程均符合一级吸收二室开放模型,SM2的主要药动学参数T1/2β、AUC、Vd、CL、Tmax、Cmax分别为25.812 h、34.066 mg/L·h、94.553 L/kg、2.608 L/h·kg、2 h、1.07 mg/L;SD的主要药动学参数T1/2β、AUC、Vd、CL、Tmax、Cmax分别为46.446 h、45.39 mg/L·h、97.207 L/kg、1.504 L/h·kg、1 h、1.17 mg/L;SMD的主要药动学参数T1/2β、AUC、Vd、CL、Tmax、Cmax分别为66.296 h、65.917 mg/L·h、40.015 L/kg、0.763 L/h·kg、2 h、2.00 mg/L。结果表明,SMD在中国对虾体内分布比SM2、SD更广泛;中国对虾体内SM2的消除相半衰期最短,SD次之,SMD消除相半衰期最长;3种磺胺类药物在中国对虾体内72 h药物吸收量SMD最高,SD次之,SM2最低;且SMD药物清除率最低,SD次之,SM2药物清除率最高,所以口服3种磺胺类药物72 h中国对虾体内SMD残留最多,SD次之,SM2残留最少。SMD在中国对虾体内药效更加持久,故在不考虑使用成本及毒副作用等其他因素的前提下,比较这3种磺胺类药物的药物代谢动力学特征,更加推荐使用SMD。     

恩诺沙星及其代谢产物在中华绒螯蟹血淋巴中的比较药代动力学

研究了不同水温(16℃、25℃)、不同给药剂量(10 mg/kg、20 mg/kg)和不同给药方式(肌注、口灌)等条件下,恩诺沙星及其代谢产物环丙沙星在中华绒螯蟹体内的药代动力学,比较了不同条件下药物在蟹血淋巴中的吸收、分布和代谢的差异。结果表明,恩诺沙星在蟹血淋巴中的药-时数据符合开放式二室模型。16℃时以10 mg/kg剂量肌注给药后,恩诺沙星在蟹血淋巴的主要药代动力学参数为:AUC96.818 mg/(L.h),Cmax6.54μg/mL,t1/2α0.851 h,t1/2β95.415 h;25℃时以10 mg/kg剂量肌注给药后,恩诺沙星的主要药代动力学参数为:AUC168.457 mg/(L.h),Cmax7.12μg/mL,t1/2α0.58h,t1/2β88.833 h;25℃时以20 mg/kg剂量肌注给药后,恩诺沙星的主要药代动力学参数为:AUC155.612 mg/(L.h),Cmax11.045μg/mL,t1/2α5.239h,t1/2β88.378 h;25℃时以10 mg/kg剂量口灌给药后,恩诺沙星的主要药代动力学参数为:AUC86.525 mg/(L.h),Cmax3.469μg/mL,t1/2α8.071h,t1/2β61.842 h。不同条件下,恩诺沙星在蟹血淋巴中的主要药代动力学参数差异较大。恩诺沙星的活性代谢产物环丙沙星在各种给药条件下的蟹血淋巴中均能检出,但含量均处于较低值,且药-时数据不能用房室模型拟合,表明恩诺沙星在蟹体内只有极少部分代谢为环丙沙星。     

Pharmacokinetics and the active metabolite of enrofloxacin in Chinese mitten-handed crab (Eriocheir sinensis)

The pharmacokinetics and active metabolite of enrofloxacin were estimated after single intramuscular administration (10.0 or 20.0 mg/kg body weight) to the Chinese mitten-handed crab (Eriocheir sinensis) in fresh water at 25.0 ± 1.0 °C. Levels of enrofloxacin and its metabolite ciprofloxacin in the main tissues (hemolymph, hepatopancreas, muscle, ovary and spermary) were simultaneously detected by HPLC. Enrofloxacin concentration–time profiles for the hemolymph in both tests were described by a two-compartment open model with first-order absorption. Distribution half-time (T_1/2), elimination half-time (T_1/2β), body clearance (CL/F), mean residence time (MRT_0–∞), area under the concentration–time curve from 0 to ∞ h (AUC_0–∞) and apparent volume of distribution (Vd/F), which derived from the pharmacokinetic model, were 0.427 h, 21.3 h, 0.133 l/h/kg, 60.0 h, 96.9 μg/ml/h and 4.08 l/kg, respectively, at a dose of 10.0 mg/kg body weight, and 0.216 h, 12.3 h, 0.189 l/h/kg, 85.8 h, 187 μg/ml/h and 3.35 l/kg, respectively, at a dose of 20.0 mg/kg body weight. Similarities were found between the hemolymph concentration–time curves of the two tests; for example, instant absorption process followed by the distribution phrase, and a second absorption peak at 6 h post-treatment. After intramuscular administration of 10.0 mg/kg body weight, absorption of enrofloxacin was observed in the main edible tissues (hepatopancreas, muscle, ovary and spermary), and the drug residue was the highest in the hepatopancreas, where the ‘drug sink’ phenomenon occurred. Comparative pharmacokinetics showed fast absorption, broad distribution and fast elimination of enrofloxacin in E. sinensis after intramuscular dosing. Regarding ciprofloxacin, the main active metabolite of enrofloxacin, though relatively low levels were detected in all the main tissues of the crab, its kinetics in the hemolymph in the two tests were not described by a one- or two-compartment open model.     

饲料中Pb和Cd在中华绒螯蟹体内的吸收与释放特性

为获知饲料中重金属与中华绒螫蟹各组织间的富集与释放特性,应用生物富集双箱动力学模型,模拟中华绒螫蟹分别在Pb含量为10.21、22.01、40.81 mg/kg,Cd含量为1.78、2.80、4.48 mg/kg的饲料驯养过程中,其鳃、肝胰腺和肌肉对Pb和Cd的生物富集与释放特性,为Pb与Cd在中华绒螫蟹体内的分布、富集和迁移提供理论依据,为中华绒螫蟹安全生产提供指导。同时通过非线性拟合得到中华绒螫蟹对饲料中Pb和Cd的富集速率常数k_1、排出速率常数k_2、生物富集系数BCF、生物半衰期B_(1/2),富集平衡时生物体内Pb和Cd含量CAmax等动力学参数。结果显示:①中华绒螫蟹对饲料中的Pb和Cd具有明显的富集,蟹鳃、肝胰腺和肌肉中Pb的含量与富集时间和饲料中Pb的添加量表现出了很好的正相关,在富集的第48天,各组织器官中Pb的含量达到最大,在鳃中的含量分别为0.18、1.14、1.27和1.91 mg/kg;肝胰腺中含量分别为1.00、2.17、2.33和3.50 mg/kg;肌肉中含量分别为0.18、0.73、1.00和1.35 mg/kg。鳃和肝胰腺对饲料中Cd的吸收与Pb情况类似,在富集的第48天,4个饲料组蟹鳃中的浓度值均达到最高,分别为0.026、0.073、0.107和0.154mg/kg;肝胰腺除了在C组实验的第24天含量达到最高,为1.90mg/kg外,其他3组实验,在富集的第48天含量达到最高分别为0.33、1.05和1.24 mg/kg,C组在第48天的含量有所降低,为1.76 mg/kg。但是肌肉中Cd含量没有明显的规律。②中华绒螫蟹对Pb和Cd的生物富集和释放都较缓慢。达到平衡状态时,鳃、肝胰腺、肌肉各组织器官中Pb含量分别为1.07~1.69、4.87~4.95、0.79~1.28 mg/kg,鳃、肝胰腺中Cd含量分别为0.06~0.14和1.25~2.66 mg/kg。Pb和Cd在组织器官中的生物富集系数(BCF)范围分别为0.03~0.48和0.03~0.87,中华绒螫蟹对Cd的富集能力明显高于Pb;Pb和Cd在各组织器官的生物学半衰期(B_(1/2))范围分别为9~67 d和8~48 d。中华绒螫蟹对Pb的排除能力明显低于Cd。③Pb和Cd在中华绒螫蟹组织器官中的富集具有选择性,在经不同含量Pb和Cd的饲料驯养后得到统一含量分布规律:肝胰腺鳃肌肉。     

亚硝态氮胁迫下凡纳滨对虾体内亚硝态氮的积累与能量代谢响应

为探究亚硝态氮胁迫下凡纳滨对虾[体长为(6.8±0.3) cm,体质量为(4.0±0.6) g]体内亚硝态氮的时空分布与能量代谢相关酶活性的响应,实验设置0(对照组)、0.8、4.0和8.0 mmol/L 4个处理组,进行持续96 h的亚硝态氮胁迫实验和12 h的恢复实验。结果显示,凡纳滨对虾死亡率与胁迫浓度呈现显著的正相关性。胁迫6 h内,亚硝态氮在凡纳滨对虾鳃、血淋巴、肠道、肝胰腺和肌肉组织中明显积累,且积累量与胁迫浓度呈现正相关。相同胁迫浓度组,亚硝态氮在对虾鳃中积累最多,肌肉中最少,鳃中的积累量约为肌肉的3倍。Na~+-K~+-ATP酶活性在0.8和4.0 mmol/L组对虾肝胰腺和肌肉中显著升高,而在8.0 mmol/L组的肌肉中显著降低。胁迫各组对虾肝胰腺AMPK活性显著上升,且与胁迫浓度呈现正相关性。恢复期间,除血淋巴(8.0 mmol/L组)外,各组织中亚硝态氮1 h恢复效率均超过50%,且肝胰腺和鳃的恢复效率最高,达到74%以上。血淋巴、鳃、肠道中亚硝态氮恢复到对照组水平的时间最短,均在6 h以内,而水体中亚硝态氮含量显著升高。以上研究表明,胁迫下亚硝态氮会在对虾组织中迅速积累,并引起能量代谢进程的加快;胁迫解除后,积累在体内的亚硝态氮能够迅速排出体外,以减轻毒性影响。本研究结果将为缓解亚硝态氮对养殖对虾毒性效应的研究提供参考。     

Pharmacokinetics of oxolinic acid and oxytetracycline in kuruma shrimp, Penaeus japonicus

The pharmacokinetics of oxolinic acid and oxytetracycline were examined in kuruma shrimp (Penaeus japonicus) after intra-sinus (10 and 25 mg/kg, respectively) and oral (50 mg/kg) administration. The shrimp were kept in tanks with recirculated artificial seawater at a salinity of 22–23 ppt. The water temperature was maintained at 25±0.6 °C. The hemolymph concentrations of both drugs after intra-sinus dosing were best described by a two-compartment open model. The distribution and elimination half-lives (t_1/2 and t_1/2β) were found to be 0.59 and 33.2 h for oxolinic acid and 0.45 and 24.7 h for oxytetracycline, respectively. The apparent volume of distribution at a steady state (V_ss) and total body clearance (CL_b) were estimated to be 1309 ml/kg and 28.8 ml/kg/h for oxolinic acid and 748 ml/kg and 22.7 ml/kg/h, respectively. The hemolymph concentration–time curves after oral administration did not fit by the nonlinear least squares method using one- and two-compartment model with first-order absorption in either of the drugs. The peak hemolymph concentration (C_max), the time to peak hemolymph concentration (t_max) and the elimination half-life were found to be 17.8 μg/ml, 7 h and 34.3 h for oxolinic acid and 24.3 μg/ml, 10 h and 33.6 h for oxytetracycline, respectively. The bioavailability (F) after oral administration was 32.9% for oxolinic acid and 43.2% for oxytetracycline. The hemolymph protein binding in vivo was determined to be 36.7±8.5% for oxolinic acid and 22.9±4.8% for oxytetracycline.     

三聚氰胺在斑点叉尾鮰体内的残留及代谢规律研究

(21±1)℃水温条件下,研究了三聚氰胺在斑点叉尾鮰(Ictalurus punctatus)体内的残留消除规律。结果显示:血浆中药时数据符合有吸收一室开放模型,动力学方程为:C=3.952660(e-0.027279t-e-0.127279t),吸收半衰期(T1/2kα)为5.4469 h,消除半衰期(T1/2ke)为25.4093 h,达峰时间(Tp)为15.4045 h,达峰浓度(Cmax)为20.3985 mg/L,表观分布容积(Vd)为2.5763(mg/kg)/(mg/L)。肌肉、肝、肾中吸收半衰期(T1/2kα)分别为3.5582、4.1884、5.4397 h,消除半衰期(T1/2ke)为50.8081、23.3504、23.7242 h,达峰时间(Tp)为14.6766、12.6524、14.9967 h,达峰浓度(Cmax)为7.6449、22.9249、40.6047 mg/L,表观分布容积(Vd)为8.5657、2.3970、1.2712(mg/kg)/(mg/L)。结果表明:药物在体内吸收迅速,药物浓度较高,分布广泛,消除较为缓慢。以80 mg/kg剂量混饲口灌3 d后,各组织中三聚氰胺含量总体呈现肾脏>肝脏>肌肉。停止灌药后第5天肌肉中及第7天肝脏和肾脏组织中三聚氰胺含量低于我国(2008)卫生部公布的乳制品及含乳食品中三聚氰胺临时管理限量值和欧盟对中国进口产品设定了三聚氰胺的最大残留限2.5 mg/kg。     

Effect of temperature on pharmacokinetics of enrofloxacin in mud crab, Scylla serrata (Forssk?l), following oral administration

The study was conducted to evaluate the pharmacokinetics of enrofloxacin following a single oral gavage (10 mg kg(-1)) in mud crab, Scylla serrata, at water temperatures of 19 and 26 degrees C. Enrofloxacin concentration in haemolymph was determined using high-performance liquid chromatography (HPLC). A multiple and repeated haemolymph sampling from the articular cavity of crab periopods was developed. The haemolymph of an individual crab was successfully sampled up to 11 times from the articular cavity. The profile of haemolymph enrofloxacin concentration of an individual crab versus time was thus achieved. The mean haemolymph enrofloxacin concentration versus time was described by a two-compartment model with first-order absorption at two water temperatures. The peak concentrations of haemolymph enrofloxacin at 19 and 26 degrees C were 7.26 and 11.03 mug mL(-1), at 6 and 2 h, respectively. The absorption and distribution half-life time ( and t(1/2alpha)) at 19 degrees C were 3.7 and 4.5 h, respectively, which were markedly larger than the corresponding values (1.1 and 1.5 h) at 26 degrees C; the elimination half-life time (t(1/2beta)) was 79.1 and 56.5 h at 19 and 26 degrees C, respectively. The area under curve (AUC), total body clearance (Cl) and mean residence time (MRT(0-infinity)) at 19 degrees C were 636.0 mg L(-1) h, 0.016 L h(-1) kg(-1) and 102.5 h, respectively; the corresponding values at 26 degrees C were 583.4 mg L(-1) h, 0.018 L h(-1) kg(-1)and 63.7 h. These results indicate that enrofloxacin is absorbed and eliminated more rapidly in mud crab at 26 degrees C than at 19 degrees C.     

中华绒螯蟹血淋巴和肝胰腺的总蛋白含量与性早熟的关系

中华绒螯蟹扣蟹性腺发育与肝胰腺和血淋巴的蛋白质浓度相关.性早熟前后,雌雄扣蟹肝胰腺总蛋白浓度分别由(121.17±44.50)mg@g-1和(89.43±21.86)mg@g-1下降至(81.08±5.84)mg@g-1和(70.58±9.90)mg@g-1,雌性扣蟹的肝胰腺占体重的比值也由8.18%降至3.90%.血淋巴总蛋白浓度正常发育的雌性扣蟹为(99.55±12.06)mg@mL-1,明显高于性早熟雌性扣蟹的(72.26±17.87)mg@mL-1;而雄性扣蟹性早熟前后的血淋巴总蛋白浓度无显著差异.肝胰腺总蛋白浓度二秋龄雌蟹高于性早熟雌性扣蟹,但它们之间的血淋巴总蛋白浓度没有显著差异.二秋龄雄蟹的血淋巴和肝胰腺总蛋白浓度与性早熟雄性扣蟹相当,差异不显著.     

Pharmacokinetics and bioavailability of oxytetracycline in vannamei shrimp (Penaeus vannamei) and the effect of processing on the residues in muscle and shell

The present study examined the pharmacokinetics and bioavailability of oxytetracycline (OTC) in vannamei shrimp (Penaeus vannamei) after intra-sinus (10 mg/kg) and oral (10 and 50 mg/kg) administration and also investigated the net changes of OTC residues in the shrimp after the thermal, acid and alkaline processing methods. The hemolymph concentrations of OTC after intra-sinus dosing were best described by a two-compartment open model. The oral bioavailability was found to be 48.2 and 43.6% at doses of 10 and 50 mg OTC/kg, respectively. The peak hemolymph concentrations after 10 and 50 mg OTC/kg doses were 3.37 and 17.4 μg/ml; the times to peak hemolymph concentrations were 7 and 10 h. The elimination half-lives were found to be 15.0 and 11.5 h for the low and high dose, respectively. The residual OTC was rapidly eliminated from muscle with the elimination half-life value of 19.4 and 15.4 h, respectively, for the groups treated with doses of 10 and 50 mg/kg. The residual OTC levels in the muscle fell below the MRL (0.2 μg/g) at 72 and 96-h post-dosing at dose levels of 10 or 50 mg/kg, respectively. Residual OTC levels in muscle and shell were approximately 20–50% lower in the thermal treatment such as boiling, baking and frying. By the acid treatment, OTC residues were reduced to >80%, while those were reduced to around 30% by alkaline treatment.